Disposable Bronchoscopes Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, Diagnostic Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2022 - 2028

Report Overview

The global disposable bronchoscopes market size was valued at USD 506.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 13.4% from 2022 to 2028. Transitioning from traditional open surgeries to minimally invasive procedures for diagnostic and therapeutic purposes is driving the growth of the market. Furthermore, the increasing incidence of lung cancer, high demand for local biopsies, growing geriatric population, and technological advancements in the field of bronchoscopy devices are bolstering the market growth. High prevalence of chronic respiratory disorders, such as lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive Pulmonary Disease (COPD), is also driving the product demand for therapeutics & diagnostics purposes to obtain tissue specimens of the lung and view abnormalities & assess growths in the airway.

As per the World Health Organization (WHO) estimates, 3.3 million individuals annually succumb to COPD. Furthermore, as per the American Cancer Society estimates, in 2018, 235,070 new cases of lung cancer and tumors were detected in the U.S., thereby boosting the demand for bronchoscopies for biopsies to detect and treat lung cancers.

In addition, as per Cancer Research U.K., 47,800 new lung cancer cases are diagnosed annually. As per the World Cancer Research Fund International, developing countries account for 58.7% of lung cancer cases. The above alarming incidence rates are anticipated to drive the product demand across the globe. Healthcare professionals are rapidly utilizing disposable bronchoscopes in diagnosing or treating respiratory ailments as it enables minimal intervention and shortens the recovery time. The development of single-use bronchoscopes to avoid the incidence of infections is also one of the key trends expected to drive the market. An increase in research initiatives focused on analyzing the efficacy of endoscopic treatments for non-cancerous diseases is also propelling the market.

Moreover, the growing global geriatric population is expected to support market growth. As per the Administration on Aging (AoA), in 2019, 16% of the U.S. population was aged 65 years & above and is expected to reach 21.6% by 2040. The growing trend of minimally invasive procedures in assessing the airway and tracheobronchial tree for respiratory tract diseases coupled with new product approvals is driving the market growth. For instance, in August 2021, Boston Scientific received U.S. FDA clearance for disposable bronchoscopes, eliminating the risk of infection usually associated with reusable bronchoscopes.

The rising preference for minimally invasive procedures is associated with their benefits, such as higher patient satisfaction, economic viability, shortened hospitalization, and reduced post-procedural complications. The risk of infection and contamination in using reusable bronchoscopes is presenting growth opportunities to the market. The COVID-19 pandemic significantly impacted the bronchoscopy market and disrupted workflows across the entire healthcare industry. Several bronchoscopy procedures, such as visualization and documentation systems, witnessed a negative impact due to the pandemic.

COVID19 disposable bronchoscopes impact: 24.4% growth in revenue from 2019 to 2020

Bronchoscopy procedures involve a high amount of risk owing to the increased pressures used to oxygenate the patient, detectible disruption of respiratory tract mucosa, close contact between a healthcare professional & patient, and generation of significant amounts of droplets & aerosols, which can contaminate procedure room equipment, personnel, and present infection risk. Although there are risks associated with bronchoscopy procedures, they remain vital and imperative procedures in diagnosis and treating respiratory diseases and cannot be postponed in certain instances. The pandemic challenged the prioritization of patients requiring prompt bronchoscopies. Lastly, the changing regulations about surgical procedures and supply chain disruptions are some of the factors that challenged the market growth during the pandemic.

End-use Insights

In 2021, the hospital's segment accounted for the highest market share of 47.4% owing to the significant product adoption & utilization rate in hospitals compared to other healthcare facilities. In addition, the growing favorable reimbursement policies and advancing healthcare infrastructure in developed & emerging economies are driving the segment growth. Hospitals are regarded as the primary health systems across several countries and account for the highest number of procedures & surgeries, which also drives the segment growth. Growing awareness levels about contamination risks and hospital-acquired infections associated with reusable devices are contributing to the high product demand in hospitals.

On the other hand, the clinics' segment is anticipated to register the fastest CAGR over the forecast years. Cost-effectiveness associated with disposable bronchoscopes compared to reusable devices is driving the adoption rate of these devices in clinics. Shortened procedure time, minimal discomfort, enhanced patient satisfaction, reduced postoperative care, and quicker recovery time are among the other benefits driving the adoption of these devices in clinics. Moreover, the growing trend of same-day surgeries is expected to propel the growth of the clinics' segment over the forecast period.

Regional Insights

North America dominated the global market with a revenue share of 41.7% in 2021. The high share was attributed to the rapid adoption of advanced technologies, demand for minimally invasive procedures, growing geriatric population, rising prevalence of chronic respiratory disorders, and advancing healthcare infrastructure in the region. The presence of several key manufacturers, suppliers, & distributors and regulatory approvals for disposable bronchoscopes is driving the growth.

On the other hand, Asia Pacific is anticipated to register the fastest growth rate over the forecast period owing to the improving healthcare infrastructure, substantial economic development, presence of lesser regulatory frameworks, growing geriatric population, and rising prevalence of lung cancers & COPD. Moreover, the increasing opportunities associated with minimally invasive procedures are attracting international investments in the region. The presence of key players with the developing startup landscape is also driving the APAC regional market growth.

Key Companies & Market Share Insights

The market is highly competitive due to the rising product demand for diagnosing and treating several lung disorders. Advancements in the market and constant product approvals from regulatory authorities are driving the market. Some of the key players operating in the global disposable bronchoscopes market are:

• Olympus Corp.

• AMBU A/S

• Boston Scientific Corp.

• Smith & Nephew, Inc.

• NeoScope, Inc.

• Pentax Medical

• Karl Storz SE & Co.

• Fujifilm Corp.

Disposable Bronchoscopes Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global disposable bronchoscopes market report on the basis of end use and region:

• End-use Outlook (Revenue, USD Million, 2014 - 2028)

  • Hospitals

  • Clinics

  • Diagnostics Centers

• Regional Outlook (Revenue, USD Million, 2014 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Italy

    • France

    • Spain

    • Russia

    • Switzerland

    • Denmark

  • Asia Pacific

    • Australia

    • China

    • Japan

    • Australia

    • New Zealand

    • Thailand

    • Indonesia

    • Malaysia

    • Vietnam

    • Philippines

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Israel

    • Qatar